PNOC041: Metformin in Patients with Recurrent or Progressive PFA Ependymoma - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
PNOC041: A Target Validation and Efficacy Study of Metformin in Patients with Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma
Principal Investigator
Daniel Landi, MD
Neuro-oncologist
Protocol Number
IRB:
PRO00119661
NCT:
NCT07226453
Phase
Phase I/II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-684-5301